Description

Wirth et al identified prognostic factors for patients with lymphocyte-predominant Hodgkin's disease treated with radiation therapy alone. These can help identify patients who may require more aggressive management and closer monitoring. The authors are from multiple cancer centers in Australia.


 

Patient selection: lymphocyte-predominant Hodgkin's disease, treated with radiation but not chemotherapy

 

Parameters affecting overall survival:

(1) age of the patient in years at diagnosis

(2) B symptoms (night sweats, fever, unintended weight loss)

(3) number of sites involved

 

Parameter

Finding

Points

age of the patient

< 45 years

0

 

>= 45 years

2

B symptoms

absent

0

 

one or more present

2

number of sites involved

1 or 2

0

 

3

1

 

4 or more

2

 

where:

• The hazard ratio for age >= 45 years was 11.5, for B symptoms 14.4, and for >= 3 sites 5.8 (3 sites) to 10.5 (more than 3 sites)

 

The risk of progression was increased if there were 3 or more sites involved (hazard ratio 9.3 for 3 sites and 19.4 for 4 or more, Figure 2 page 1225).

 

The original paper does not use a risk score. One was developed to utilize the data in the paper.

 

total risk score =

= SUM(points for all 3 parameters)

 

Interpretation:

• minimum score: 0

• maximum score: 6

• The higher the score the greater the worse the overall survival.

• Radiation therapy can give excellent results with Stage I or Stage II disease with 1-2 sites of involvement. A full mantle field was not needed to ensure freedom from disease progression.

 


To read more or access our algorithms and calculators, please log in or register.